Drug-resistant mutants of HIV-1 in patients exhibiting increasing CD4 cell count despite virological failure of highly active antiretroviral therapy-Reference-Cited by-同舟云学术

Drug-resistant mutants of HIV-1 in patients exhibiting increasing CD4 cell count despite virological failure of highly active antiretroviral therapy

Published:2001-11 Issue:17 Volume:15 Page:2325-2327
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:AIDS

Author:

Antinori Andrea,Liuzzi Giuseppina,Cingolani Antonella,Bertoli Ada,Di Giambenedetto Simona,Trotta Maria P.,Rizzo Maria G.,Girardi Enrico,De Luca Andrea,Perno Carlo F.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference13 articles.

1. Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection

2. Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centre

3. Resistance Mutations in Protease and Reverse Transcriptase Genes of Human Immunodeficiency Virus Type 1 Isolates from Patients with Combination Antiretroviral Therapy Failure

4. CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART)

5. Discrepant responses to triple combination antiretroviral therapy in advanced HIV disease

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The association between detected drug resistance mutations and CD4+ T-cell decline in HIV-positive individuals maintained on a failing treatment regimen;Antiviral Therapy;2017

2. Characterization of two HIV-1 infectors during initial antiretroviral treatment, and the emergence of phenotypic resistance in reverse transcriptase-associated mutation patterns;Virology Journal;2015-11-14

3. Significant Reductions in Gag-Protease-Mediated HIV-1 Replication Capacity during the Course of the Epidemic in Japan;Journal of Virology;2012-11-14

4. Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy;Retrovirology;2012-08-13

5. Molecular and structural aspects of clinically relevant mutations related to the approved non-nucleoside inhibitors of HIV-1 reverse transcriptase;Drug Resistance Updates;2011-06